Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-25-003707
Filing Date
2025-05-15
Accepted
2025-05-15 16:12:31
Documents
7
Effectiveness Date
2025-05-15

Document Format Files

Seq Description Document Type Size
1 S-8 actuate_s8.htm S-8 38569
2 ACTUATE THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN actuate_ex0402.htm EX-4.2 132640
3 OPINION OF BAKER & HOSTETLER LLP actuate_ex0501.htm EX-5.1 6198
4 CONSENT OF CROWE LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM actuate_ex2301.htm EX-23.1 3010
5 CONSENT OF KMJ CORBIN & COMPANY LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FI actuate_ex2302.htm EX-23.2 2394
6 CALCULATION OF FILING FEE TABLE actuate_ex107.htm EX-FILING FEES 9800
7 GRAPHIC image_001.jpg GRAPHIC 2989
  Complete submission text file 0001683168-25-003707.txt   198023
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287317 | Film No.: 25953140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)